1. Home
  2. OZ vs INBX Comparison

OZ vs INBX Comparison

Compare OZ & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belpointe PREP LLC Units

OZ

Belpointe PREP LLC Units

HOLD

Current Price

$64.89

Market Cap

230.0M

Sector

N/A

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$86.53

Market Cap

430.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OZ
INBX
Founded
2020
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.0M
430.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
OZ
INBX
Price
$64.89
$86.53
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
17.3K
232.9K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,217,000.00
$1,400,000.00
Revenue This Year
N/A
$563.00
Revenue Next Year
N/A
$230.77
P/E Ratio
N/A
N/A
Revenue Growth
244.98
N/A
52 Week Low
$56.77
$10.81
52 Week High
$82.89
$94.47

Technical Indicators

Market Signals
Indicator
OZ
INBX
Relative Strength Index (RSI) 59.38 58.68
Support Level $63.47 $74.80
Resistance Level $69.00 $94.47
Average True Range (ATR) 1.25 6.40
MACD 0.80 -1.07
Stochastic Oscillator 62.62 59.63

Price Performance

Historical Comparison
OZ
INBX

About OZ Belpointe PREP LLC Units

Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: